Lv4
708 积分 2024-06-28 加入
An update on redifferentiation strategies for radioactive iodine-refractory differentiated thyroid carcinoma
2个月前
已完结
Transforming thyroid cancer management: the impact of neoadjuvant therapy
3个月前
已完结
Sacituzumab Govitecan in Untreated, Advanced Triple-Negative Breast Cancer
3个月前
已完结
Radioiodine Plus Low-Dose Lenvatinib in Radioiodine-Sensitive High-Volume Metastatic Differentiated Thyroid Cancer
4个月前
已完结
Results of a Phase Ib Study Investigating Durvalumab in Combination with Eribulin in Patients with HER2-Negative Metastatic Breast Cancer and Recurrent Ovarian Cancer
4个月前
已完结
Early versus deferred use ofCDK4/6 inhibitors in advanced breast cancer
6个月前
已完结
Outcomes of subsequent treatment regimens after trastuzumab deruxtecan in patients with metastatic breast cancer
6个月前
已完结
The Lancet Commission on addressing the global hepatocellular carcinoma burden: comprehensive strategies from prevention to treatment
7个月前
已完结
Long and short-term efficacy and safety comparison of nab-paclitaxel versus paclitaxel combined with trastuzumab and pertuzumab for neoadjuvant treatment of HER2-positive breast cancer: A systematic review and meta-analysis
8个月前
已完结
BAT mitochondria: whitening meets softening
7个月前
已采纳
Tripeptide armour shields encapsulated proteins
7个月前
已采纳
Tripeptide armour shields encapsulated proteins
7个月前
已采纳
Tripeptide armour shields encapsulated proteins
7个月前
已采纳
Efficacy and safety of tirzepatide, GLP‐1 receptor agonists, and other weight loss drugs in overweight and obesity: a network meta‐analysis
8个月前
已撤回
Colibactin‐positive Escherichia coli induce a procarcinogenic immune environment leading to immunotherapy resistance in colorectal cancer
8个月前
已采纳
Gastric precancerous process in a high risk population: cohort follow-up
8个月前
已采纳
皖公网安备34019202002308
